Cargando…
Paroxysmal and Non-Paroxysmal Atrial Fibrillation in Middle Eastern Patients: Clinical Features and the Use of Medications. Analysis of the Jordan Atrial Fibrillation (JoFib) Study
(1) Background: Atrial fibrillation (AF) is the most common arrhythmia causing an increased risk of mortality and morbidity. It is classified into paroxysmal and non-paroxysmal AF depending on the duration and frequency of the episodes. (2) Aims: Our goal was to investigate and compare the clinical...
Autores principales: | Al-Makhamreh, Hanna, Alrabadi, Nasr, Haikal, Lubna, Krishan, Mohammad, Al-Badaineh, Noor, Odeh, Osama, Barqawi, Tawfiq, Nawaiseh, Mohammed, Shaban, Ala, Abdin, Basil, Khamies, Lama, Hammoudeh, Ayman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141457/ https://www.ncbi.nlm.nih.gov/pubmed/35627709 http://dx.doi.org/10.3390/ijerph19106173 |
Ejemplares similares
-
Impact of thyroid disease in patients with atrial fibrillation: Analysis from the JoFib registry
por: Al-Makhamreh, Hanna, et al.
Publicado: (2022) -
One-Year Clinical Outcome in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study
por: Hammoudeh, Ayman, et al.
Publicado: (2022) -
Demographics and Risk Profile of Elderly Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study
por: Alhaddad, Zayd, et al.
Publicado: (2022) -
Thromboembolism and Major Bleeding in Patients with Atrial Fibrillation and EHRA Type 2 Valvular Heart Disease: The Jordan Atrial Fibrillation (JoFib) Study
por: Al-Najar, Mahasen, et al.
Publicado: (2023) -
Adherence to the 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline on the Use of Oral Anticoagulant Agents in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study
por: Hammoudeh, Ayman J., et al.
Publicado: (2021)